MTI

Mobile Healthcare Softwaremti.co.jp

Company typePrivate
Founded1996
HeadquartersShinjuku, Japan
Headcount1,001–5,000
GTM typeB2B and B2C
OfferingSoftware

MTI firmographics

Firmographics

Name: MTI
Legal name: 株式会社エムティーアイ
Website: https://mti.co.jp
Company type: Private
Founded year: 1996
Operating status: Operating
Headcount range: 1,001–5,000 employees
Ownership category
akta.pro rank

MTI industry classification

Industry

Product category: Mobile Healthcare Software
NAICS: Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers (516210)
SIC: Services-Health Services (8000)
akta.pro primary industry: Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
akta.pro secondary industries: Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH), Women’s Health & Fertility Tracking Devices (Ovulation/Temp Sensors, Pelvic Health Devices) (CRACAQAJ)

Keywords

Women's health applications
Maternal child health apps
Cloud pharmacy software
Mobile healthcare services
Weather hazard detection

Where MTI is headquartered

Location

Headquarters

HQ city: Shinjuku
HQ country: Japan
HQ region: Asia

Offices2 records

Markets served

MTI business model

Business model

GTM type: B2B and B2C
Offering type: Software
Cost components: Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

Consumer App Subscriptions: Premium subscription services for individual consumers through smartphone apps (iOS/Android), offering enhanced features beyond free tier. Services include ルナルナ premium course and other lifestyle/health applications.
Government/Public Sector Services: B2G partnerships with prefectures and municipalities where MTI provides its platforms (ルナルナ, 母子モ) free to residents, with public funding supporting service delivery. Multiple prefectural and city partnerships for women's health support.
Enterprise Healthcare Solutions: B2B services including cloud-based pharmacy management systems (CARADA電子薬歴 Solamichi) and AI-powered medical support tools for corporate healthcare and pharmacy chains.
Group Company Services: Revenue from subsidiary operations including 母子モ (maternal-child health app), ソラミチシステム (pharmacy solutions), and other group companies providing various digital health services.

Pricing tiers

Model	Billing	Price
Freemium	Monthly	Free tier with basic features
Subscription	Monthly	Premium subscription for ルナルナ

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

MTI product offering

Product offering

Core offering

MTI operates a mobile content and digital health platform offering smartphone-based services for consumers and public-sector partners. Its core offerings include the ルナルナ (Lunarna) women's health tracking app with proprietary ovulation prediction, the 母子モ (Boshi Mo) maternal and child health handbook app, the CARADA電子薬歴Solamichi cloud pharmacy record system, and the 3D雨雲ウォッチ (3D Rain Cloud Watch) guerrilla rainstorm and hail detection app. The company also distributes music, e-books, and lifestyle content via its music.jp platform and subsidiaries.

Differentiator

Problem solved

Functional benefit

Brands

ルナルナ: Women's healthcare service app for menstrual management, fertility tracking, pregnancy support, and menopause care with over 23 million cumulative downloads
母子モ
ルナルナファミリー
ルナルナビューティー
ルナルナマタニティ
CARADA 電子薬歴 Solamichi
3D雨雲ウォッチ
music.jp
ルナルナLite
ルナルナおくすり便
ルナルナメディコ

Products and services

ルナルナ (Lunarna)
母子モ (Boshi Mo)
CARADA電子薬歴Solamichi
3D雨雲ウォッチ (3D Rain Cloud Watch)
AI薬歴作成支援サービス corte
music.jp

Quantifiable outcome

2,300万+ cumulative downloads for ルナルナ app
+3 more outcomes

Companies that use MTI

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles3 records

MTI technology and API

Technology

Technology focussed Yes

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Integration25 records

AI capability16 records

Feature3 records

MTI partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered major and core.

Ocean Network Express (ONE)majorStrategic or Co-development Partner · 1 December 2025Established joint venture QUAVEO Company Limited in Ho Chi Minh City, Vietnam to drive digital transformation in container shipping through AI technology. MTI holds 51%, ONE holds 49%. Initial capital of 1.6 million USD. Plans to expand beyond maritime to distribution and manufacturing sectors.
Aioi Nissay Dowa Insurance (あいおいニッセイ同和損保)coreStrategic or Co-development PartnerJoint research since 2022 on hail prediction technology, resulting in development of hail risk prediction algorithm integrated into 3D雨雲ウォッチ app. Enables 30-minute advance warning of hail risks with push notifications.
National Center for Child Health and Development (国立成育医療研究センター)coreStrategic or Co-development PartnerResearch collaboration using ルナルナ user data for large-scale studies on PMS/PMDD. Published findings in International Journal of Gynecology & Obstetrics in December 2025.
Multiple Japanese MunicipalitiescoreGTM or Marketing PartnerPartnerships with prefectures (Tochigi, Yamanashi, Okayama, Niigata, Miyagi) and cities (Kamakura, Ikomachi, Fukui, etc.) to provide ルナルナ premium services free to residents for women's health and preconception care support.
Solamichi Systems (株式会社ソラミチシステム)coreStrategic or Co-development PartnerSubsidiary developing CARADA electronic pharmacy records and AI medication guidance solutions. Partnerships with 日本调剂 (763 stores), トモズ, キリン堂, 薬樹 for deployment of cloud pharmacy systems and AI tools.
corte Inc.coreTechnology or IntegrationJoint development of AI medication record service 'corte' with Solamichi Systems and Japan Medical Pharmacy (日本调剂). Includes patent application for medication guidance scoring functionality.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

MTI competitors and assessment

Company assessment

Regional players

MedPeer, Inc. Japanese physician community platform with MR-kun and clinical decision support tools. Regional comparable serving Japanese healthcare stakeholders with digital tools.

Direct peers

CureApp Inc. Japanese digital therapeutics company developing prescription-grade software therapeutics. Direct comparable as a Japan-based digital health company applying software/AI to clinical and consumer health applications.
Welbe Inc. Japanese femtech company offering online pill delivery and women's health services. Direct domestic peer competing in the same Japanese women's health subscription space.
M3 Inc. Japan's largest digital healthcare platform (m3.com for physicians, medical marketing, MR-kun). Directly comparable as a Japanese-listed digital health company leveraging data and platform economics across healthcare stakeholders.
Flo Health: Global women's health app with period/fertility tracking and AI-powered insights. Direct competitor to Lunarna in the women's health app category, particularly for premium subscription offerings.
Clue: Berlin-based period and ovulation tracking app with strong global brand. Direct peer to Lunarna in the B2C femtech subscription market with overlapping target users.
Natural Cycles: FDA-cleared digital fertility tracking app with proprietary algorithm. Direct comparable as a women's health subscription app with patented prediction technology.

Emerging players

Biofourmis: Global AI-powered remote patient monitoring and digital therapeutics company. Emerging peer with overlap in AI-driven health monitoring and chronic care management.
iCARE Co., Ltd. Japanese employee health management SaaS (Carely) provider. Comparable as a Japanese digital health company serving B2B/B2G clients with health management technology.

Broad incumbents

DeNA Co., Ltd. Major Japanese mobile internet conglomerate with healthcare and entertainment verticals (including Mobaoku, SHOWROOM, healthcare AI). Comparable as a larger Japanese mobile/health platform with broader portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

MTI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MTI leadership team

Management profile

Number of profiles

Profiles9 records

MTI subsidiaries and ownership

Company hierarchy

Subsidiaries17 records

MTI funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MTI M&A and investment

M&A and investment

M&A4 records

Investments10 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MTI

What does MTI do?

Is MTI a public or private company?

MTI is a private company. It is classified as public and is currently operating.

When was MTI founded?

MTI was founded in 1996. It employs 1,001 to 5,000 people.

Where is MTI based?

MTI is headquartered in Shinjuku, Japan, in the Asia region.

How does MTI make money?

Four revenue lines are on record. Consumer App Subscriptions are the primary driver. The others are government/Public Sector Services, enterprise Healthcare Solutions and group Company Services.

Who are MTI's main competitors?

MedPeer, Inc. is listed as a regional player. Direct peers are CureApp Inc., Welbe Inc., M3 Inc., Flo Health, Clue and Natural Cycles. Emerging players are Biofourmis and iCARE Co., Ltd.. DeNA Co., Ltd. is listed as a broad incumbent.

Does MTI have an API?

No public API is recorded for MTI.

What industry is MTI in?

MTI's product category is Mobile Healthcare Software. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HLACAKAH, Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools. Its NAICS code is 516210 and its SIC code is 8000.